RIA
ALXN

RPG Investment Advisory’s Alexion Pharmaceuticals ALXN Stock Holding History

RPG Investment Advisory’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-125
Closed -$23K – 365
2021
Q2 		$23K Hold
125
– – ﹤0.01% 169
2021
Q1 		$19K Hold
125
– – ﹤0.01% 177
2020
Q4 		$20K Hold
125
– – ﹤0.01% 164
2020
Q3 		$14K Hold
125
– – ﹤0.01% 169
2020
Q2 		$14K Hold
125
– – ﹤0.01% 171
2020
Q1 		$11K Hold
125
– – ﹤0.01% 168
2019
Q4 		$14K Hold
125
– – ﹤0.01% 164
2019
Q3 		$12K Hold
125
– – ﹤0.01% 165
2019
Q2 		$16K Hold
125
– – ﹤0.01% 158
2019
Q1 		$17K Hold
125
– – ﹤0.01% 169
2018
Q4 		$12K Hold
125
– – ﹤0.01% 179
2018
Q3 		$17K Hold
125
– – ﹤0.01% 177
2018
Q2 		$16K Hold
125
– – ﹤0.01% 187
2018
Q1 		$14K Sell
125
-5,222
-98% -$624K ﹤0.01% 251
2017
Q4 		$639K Sell
5,347
-74
-1% -$9.01K 0.16% 89
2017
Q3 		$761K Sell
5,421
-100
-2% -$13.6K 0.19% 82
2017
Q2 		$672K Buy
5,521
+217
+4% +$25.3K 0.18% 86
2017
Q1 		$643K Sell
5,304
-341
-6% -$44K 0.19% 88
2016
Q4 		$690K Sell
5,645
-200
-3% -$24.5K 0.23% 79
2016
Q3 		$716K Sell
5,845
-200
-3% -$25.7K 0.22% 82
2016
Q2 		$705K Buy
6,045
+505
+9% +$71.7K 0.19% 88
2016
Q1 		$771K Sell
5,540
-165
-3% -$24.2K 0.3% 75
2015
Q4 		$1.09M Buy
+5,705
New +$997K 0.41% 65

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

RPG Investment Advisory's ALXN Position: Q3 2021 in Review

RPG Investment Advisory sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 125 shares — an estimated $23K sold.

RPG Investment Advisory first reported a position in ALXN in Q4 2015 and held it in 23 quarters. The position peaked at $1.09M in Q4 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • RPG Investment Advisory reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • RPG Investment Advisory sold 125 Alexion Pharmaceuticals shares in Q3 2021, an estimated $23K.
  • RPG Investment Advisory first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 23 quarters.
  • RPG Investment Advisory's Alexion Pharmaceuticals position peaked at $1.09M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on RPG Investment Advisory's 13F filing for Q3 2021, filed 25 Oct 2021.